Skip to main content

Accelerating private equity deal flows with Claude

TL;DR

  • An AI-powered "Claude" platform drastically accelerates the financial deal flow process, condensing it from days to mere hours by automating crucial tasks.
  • The system enhances due diligence by autonomously identifying critical risks, such as expiring contracts or short-term termination clauses, that human analysts might easily overlook.
  • Claude automates the creation of financial models, performs stress tests, and provides investment recommendations, enabling faster and more informed decision-making throughout the deal lifecycle.

Takeaways

  • Claude automates the creation of client-ready deal teasers in under two minutes by extracting financial, customer, and operational data from various sources.
  • It can quickly screen deals and build comprehensive Leverage Buyout (LBO) models, incorporating investment criteria and data from initial teasers.
  • The platform performs deep due diligence by analyzing data room files to identify critical risks, such as expiring contracts (e.g., 18% of revenue with a contract expiring December 2025) or short-term termination clauses (e.g., 28% of revenue).
  • Claude generates complete financial models, including pricing (e.g., 11 times EBITDA), leverage (e.g., 5 times), 5-year cash flow projections, debt amortization, and multiple cases (upside, base, downside), in minutes.
  • Users can conduct real-time stress testing and sensitivity analysis, creating new scenarios with varied assumptions and evaluating returns across different exit multiples (e.g., 8 to 12 times exit).
  • The tool synthesizes all analyses into an investment committee deck, providing Letter of Intent (LOI) recommendations (e.g., 10 to 11 times EBITDA) and flagging pre-LOI conditions based on identified risks.
  • The entire deal flow process, from data room to investment recommendation, is accelerated from days to approximately 48 hours, with initial steps taking mere minutes.

Vocabulary

Deal Teaser — A brief marketing document that provides key information about a company being offered for sale, designed to generate interest from potential buyers. LBO Model — A financial model used to analyze the acquisition of a company using a significant amount of borrowed money (leverage) to meet the cost of the acquisition. Data Room — A secure physical or virtual space where confidential documents related to a business transaction (e.g., mergers, acquisitions) are stored and reviewed by interested parties during due diligence. EBITDA — Earnings Before Interest, Taxes, Depreciation, and Amortization; a measure of a company's operating performance often used as a proxy for cash flow. Leverage — The use of borrowed capital (debt) to finance an investment or a company's assets, aiming to amplify the potential returns (or losses) on an investment. Debt Amortization — The process of gradually paying off a debt over time through a series of regular payments, where each payment includes both principal and interest. IRR (Internal Rate of Return) — The discount rate that makes the net present value (NPV) of all cash flows from a particular project or investment equal to zero, used to evaluate the attractiveness of an investment. Money Multiple — A metric in private equity representing the total cash proceeds received from an investment divided by the total cash invested, often expressed as "x times money." Sensitivity Analysis — A financial modeling technique used to determine how different values of an independent variable (e.g., exit multiple, growth rate) impact a particular dependent variable (e.g., IRR). Letter of Intent (LOI) — A non-binding document outlining the preliminary agreement between two parties before a final, legally binding contract is executed, often used in M&A deals.

Transcript

Let's look at how Claude Accelerates Previdec would ideal flow from days to hours. We'll follow Sarah and associate our Riverside partners on the cell side. In Gen, a VP at World Capital on the Bioside. They're working on Horizon Health Group, an $85 million healthcare services business. Sarah needs a deal teaser and asks Claude to create a client-ready presentation using the deal teaser skill. Claude searches ignite, finding financials, customer analysis and operations data, and extracting revenue, margins, retention metrics and facility details. In under two minutes, Sarah's got a professional teaser ready to send. The teaser lands in Gen's inbox. She asks Claude to screen it and build a leverage biomodel using the LBO skill. Claude pulls from SharePoint for investment criteria and extracts data from the teaser. With the minutes, Gen gets a comprehensive screening memo and sees that Horizon Health seems to check all the boxes. But Claude is deeper diligence. The search is the ignite data room to find that Blue Cross Regional is 18% of revenue, with a contract that expires December 2025. 28% of revenue has short-term termination clauses. This is risk that wouldn't have been picked up at a glance. The verdict, conditional pass, that Blue Cross Renewal needs to be locked down. Now Gen looks at the numbers, Claude built a complete model in minutes, which would have taken an analyst hours. Which is priced at 11 times EBITDA, 5 times leverage, with 5-year cash flow projections and a debt amortization, an upside and base case. Base case shows 26% IR and 3 times money multiple, well above the 20% hurdle. Gen's stress tests with Claude, asking to add a downside case in Excel. Claude immediately builds a new scenario with lower growth in margin assumptions. Gen sees Claude's work in real time and validates its assumptions. Claude uses 19% IR right after a short. Then she asks for sensitivity analysis. Claude builds matrix, a time to 12 time exits. At 10 times, the numbers tie exactly to the model. Even at 8 times, the returns are acceptable. The fan of outcomes look good. This Monday morning, and Gen has an investment committee meeting in a few hours. She asks Claude to synthesize everything with a letter of intent recommendation. In minutes, Gen receives an investment committee deck with a recommendation to proceed with a letter of intent at 10 to 11 times EBITDA. Claude flags contract risks as pre-LLI conditions. Base case generates 26% IR, downside 19%. LLI recommendation 11 times if Blue Cross is locked down, take off return if not. Sarah went from Datarum to teaser in two minutes. Gen took teaser to an investment recommendation in 48 hours. Claude caught a material contract risk by reading the Datarum files, then quantify the deal still works. This is better diligence, faster.

Feedback / ReportSpotted an issue or have an improvement idea?